Top Life Sciences Omnichannel Agencies to Work With - June 2026
Introduction
Life science omnichannel marketing has moved from aspiration to commercial imperative. Healthcare professionals today interact with pharmaceutical and biotech companies across a growing range of channels, including field visits, medical congresses, digital platforms, approved email, peer networks, and patient advocacy groups, and they expect those interactions to be coherent, personalised, and relevant to their specific clinical context. The life sciences companies that have built the omnichannel infrastructure to meet these expectations consistently outperform those that continue to manage channels in silos, and the performance gap between coordinated and fragmented engagement is widening.
Multichannel marketing in life sciences is not simply about adding digital touchpoints to a field-force-centric model. It requires a fundamental redesign of the commercial engagement architecture, including data integration, content strategy, channel orchestration, and the analytics layer that makes personalisation at scale operationally sustainable. The agencies below have been selected for their demonstrated expertise in life science omnichannel marketing and for their ability to deliver coordinated, data-driven engagement programmes that generate measurable commercial outcomes.
Top 10 Life Sciences Omnichannel Agencies
1. G&CO.
G&CO. is a global strategy and experience consultancy that helps life sciences and biotech companies design and execute omnichannel strategy solutions for life sciences that connect HCP, patient, and partner engagement across every channel in a coordinated, data-driven commercial model. G&CO.’s approach to life science omnichannel marketing treats channel coordination not as a technology challenge but as a commercial strategy challenge: the question is not which channels to use but how to orchestrate them so that every interaction builds on the last, every message is relevant to the stakeholder’s specific context, and every engagement decision is informed by a unified view of the relationship.
G&CO. works with life sciences clients across the full omnichannel engagement lifecycle, from channel strategy and content architecture through CRM integration, field and digital coordination, and the analytics infrastructure that measures commercial outcomes rather than engagement volume. Through the Acumen platform, G&CO. provides the brand and consumer intelligence that informs which channels, messages, and engagement approaches resonate most with each audience segment, ensuring that omnichannel investment is directed where it will generate the highest commercial return.
G&CO. is a certified minority business enterprise through the National Minority Supplier Development Council (NMSDC). For life sciences organisations with diversity and inclusion requirements in their procurement process, G&CO. meets the criteria for MBE-qualified partner status.
Best suited for: Life sciences and biotech companies at commercial stage seeking a strategy partner that can design and implement a coordinated multichannel marketing life sciences programme, particularly those moving from field-force-centric models to integrated digital and physical engagement architectures.
2. Inizio
Inizio is a global health engagement company with deep capabilities in life science omnichannel strategy, content production, and channel orchestration for pharmaceutical and biotech commercial teams. Inizio’s approach combines strategic advisory with creative execution and technology implementation, enabling clients to design and deliver engagement programmes that reach HCPs and patients across medical, commercial, and marketing channels in a coordinated way. The firm’s scale and integrated service model make it well suited to large pharmaceutical organisations managing complex, multi-market omnichannel programmes.
Best suited for: Large pharmaceutical companies seeking a full-service omnichannel engagement partner that integrates strategy, creative content, and technology implementation across HCP and patient channels at multinational scale.
3. Viseven
Viseven is a life sciences-focused digital engagement platform and services company with particular strength in modular content, eDetailer development, and omnichannel campaign execution. The firm helps pharmaceutical commercial teams build scalable content operations that support personalised HCP engagement across approved email, digital detail aids, and self-detailing platforms. Viseven’s combination of technology platform and content services makes it a practical partner for organisations building out their life science omnichannel marketing capability at the content and channel execution layer.
Best suited for: Pharmaceutical commercial teams seeking scalable modular content and digital channel execution capabilities for HCP engagement, particularly those building eDetailer programmes, approved email campaigns, or self-detailing workflows as part of a broader omnichannel strategy.
4. IQVIA
IQVIA’s OCE (Orchestrated Customer Engagement) platform provides pharmaceutical commercial teams with a unified environment for managing multichannel marketing in life sciences, integrating HCP engagement data from field visits, digital interactions, medical affairs engagements, and events into a single commercial intelligence layer. IQVIA’s proprietary healthcare data assets give its omnichannel strategy recommendations a market intelligence foundation that few competitors can match, making it a powerful partner for organisations seeking to ground their channel strategy in real prescribing and engagement data.
Best suited for: Large pharmaceutical companies seeking to integrate field, digital, and medical affairs engagement data into a unified omnichannel commercial intelligence platform, particularly those that want to leverage IQVIA’s proprietary healthcare data for HCP targeting and next-best-action recommendations.
5. Publicis Health
Publicis Health is a global health communications network with substantial life science omnichannel marketing capabilities spanning strategy, creative, data, and technology. The firm designs and executes omnichannel engagement programmes for pharmaceutical and biotech clients across HCP, patient, and payer audiences, bringing together the strategic, creative, and analytical capabilities required to orchestrate consistent, personalised engagement at global scale. Publicis Health’s access to the broader Publicis Groupe data and technology infrastructure gives it a meaningful competitive advantage in data-driven omnichannel programme design.
Best suited for: Multinational pharmaceutical companies seeking a global omnichannel engagement partner with integrated strategy, creative, data, and technology capabilities across HCP, patient, and payer channels.
6. Tredence
Tredence is a data science and AI company with strong capabilities in the analytical and data engineering layer of life science omnichannel marketing. The firm works with pharmaceutical and biotech companies to build the unified HCP data models, next-best-action recommendation engines, and engagement analytics infrastructure that make omnichannel strategy solutions for life sciences commercially intelligent rather than channel-additive. Tredence’s focus on the data and AI layer of omnichannel programmes makes it a strong specialist partner for organisations that need to unlock the commercial potential of their existing channel investments.
Best suited for: Pharmaceutical and biotech companies with existing omnichannel channel infrastructure seeking to improve commercial performance through advanced HCP data modelling, AI-driven next-best-action recommendations, and engagement analytics.
7. Klick Health
Klick Health is one of the largest independent health agencies in the world, with comprehensive life science omnichannel marketing capabilities spanning brand strategy, digital experience, data science, CRM, and channel execution. The firm works with pharmaceutical and biotech companies on the full spectrum of omnichannel engagement, from the strategic architecture through the content, technology, and analytics that make it commercially operational. Klick is particularly well regarded for its proprietary technology infrastructure, which enables real-time campaign optimisation and advanced HCP targeting across regulated pharmaceutical marketing environments.
Best suited for: Pharmaceutical companies with substantial marketing investment seeking a full-service omnichannel health agency with proprietary technology infrastructure, deep data science capability, and a track record of delivering commercially measurable HCP and patient engagement programmes.
8. Syneos Health
Syneos Health is a biopharmaceutical solutions organisation with significant capabilities in multichannel marketing life sciences, clinical and commercial deployment, and patient engagement. The firm supports pharmaceutical and biotech companies across the full commercial lifecycle, including launch strategy, field force deployment, and the omnichannel commercial infrastructure that connects field and digital engagement. Syneos Health’s combination of clinical, regulatory, and commercial capabilities makes it well suited to organisations managing the transition from clinical to commercial stage.
Best suited for: Pharmaceutical and biotech companies approaching commercial launch seeking an integrated clinical and commercial partner with strong multichannel marketing capabilities and field force deployment experience.
9. Agilisium
Agilisium is a data and AI company with growing life sciences capabilities in omnichannel HCP engagement, commercial analytics, and next-best-action modelling. The firm works with pharmaceutical commercial teams to build the data infrastructure and AI-driven engagement models that enable personalised, channel-coordinated HCP outreach. Agilisium’s focus on AI-powered commercial intelligence positions it as a specialist partner for organisations seeking to move from reactive multichannel execution to predictive, data-driven omnichannel engagement.
Best suited for: Pharmaceutical commercial teams seeking AI-driven omnichannel engagement capabilities, particularly those building or enhancing next-best-action recommendation models and predictive HCP targeting programmes.
10. Beghou Consulting
Beghou Consulting is a life sciences commercial analytics and operations consultancy with strong capabilities in omnichannel strategy design, sales force effectiveness, and commercial intelligence. The firm helps pharmaceutical and biotech companies design the commercial operating model and analytics infrastructure that supports coordinated multichannel engagement, including territory design, channel mix optimisation, and the performance measurement frameworks that connect omnichannel investment to commercial outcomes. Beghou’s deep commercial operations expertise makes it a strong partner for organisations seeking to optimise the efficiency and effectiveness of their life science omnichannel marketing investment.
Best suited for: Pharmaceutical and biotech companies seeking commercial analytics and operations support for omnichannel strategy design, sales force effectiveness optimisation, and the performance measurement frameworks that connect channel investment to prescribing outcomes.
%20(1).png)
Let’s kickstart the conversation and design stuff people will love.
The Retail & Consumer Index
What Is a Life Sciences Omnichannel Agency?
A life sciences omnichannel agency is a specialist firm that helps pharmaceutical, biotech, and medtech companies design, build, and execute coordinated commercial engagement programmes across every channel through which they interact with healthcare professionals, patients, payers, and partners. Unlike multichannel agencies that manage individual channels independently, omnichannel agencies integrate channels through shared data, coordinated content, and unified engagement measurement, creating a commercial experience that is coherent and personalised regardless of which channel the stakeholder uses.
Life science omnichannel is a strategic capability, not a technology deployment. The foundation is a unified HCP and patient data model that gives the commercial organisation a single, continuously updated view of each stakeholder’s engagement history, content preferences, and prescribing behaviour. On top of that data foundation, the omnichannel agency designs the engagement architecture that determines which channel, which message, and which timing is most likely to generate the desired commercial response for each individual stakeholder.
Omnichannel strategy solutions for life sciences must account for the specific constraints of the regulated healthcare environment, including promotional compliance requirements, medical-legal review processes, privacy regulations governing HCP and patient data, and the channel preferences that differ significantly between therapeutic areas and geographies. The best life sciences omnichannel agencies bring regulatory awareness alongside commercial and digital expertise, ensuring that the engagement programmes they design are both commercially effective and operationally compliant.
What Services Do Life Sciences Omnichannel Agencies Provide?
Omnichannel Strategy and Channel Architecture
Life sciences omnichannel agencies develop the channel strategy and engagement architecture that determines how a pharmaceutical or biotech company will coordinate its interactions with HCPs, patients, and payers across field, digital, and events channels. This includes channel mix analysis, engagement journey design, content strategy, and the HCP and patient segmentation that ensures each stakeholder receives the right engagement through the right channel at the right time.
CRM and Data Integration
Effective life science omnichannel marketing depends on a unified data foundation that integrates engagement data from every channel into a single HCP or patient profile. Omnichannel agencies with CRM and data integration capabilities help clients connect field CRM, digital engagement platforms, approved email systems, event management tools, and patient support programme data into a coherent commercial intelligence layer.
Content Strategy and Modular Content Development
Omnichannel engagement at scale requires content that can be personalised for different stakeholder segments, adapted for different channels, and updated in real time without requiring full content recreation. Life sciences omnichannel agencies with modular content capabilities help clients build content libraries and production workflows that support personalised, compliant engagement across all channels simultaneously.
Next-Best-Action and Commercial Intelligence
The most commercially advanced life science omnichannel marketing programmes use AI-driven next-best-action models to recommend the optimal channel, message, and timing for each HCP interaction. Omnichannel agencies with commercial intelligence capabilities design and implement these recommendation engines, giving field teams and digital channel managers the insights they need to prioritise their engagement in real time.
Omnichannel Performance Measurement
Measuring the commercial impact of multichannel marketing in life sciences requires connecting engagement metrics across every channel to downstream outcomes including prescribing behaviour, patient adherence, and market access progress. Life sciences omnichannel agencies design the measurement frameworks and analytics dashboards that make this connection operationally possible, giving commercial leaders visibility into which channel investments are generating the strongest return.
Field and Digital Coordination
One of the most commercially valuable capabilities a life sciences omnichannel agency can provide is the design and implementation of coordinated field and digital engagement workflows. This includes the CRM integration that gives field representatives visibility of a HCP’s digital engagement history before a visit, the approved email follow-up that reinforces a field message within a clinically relevant timeframe, and the event-triggered digital content that arrives when a HCP’s behaviour signals readiness to engage.
How to Choose the Right Life Sciences Omnichannel Agency
– Strategy versus execution capability: some life sciences omnichannel agencies are strong at strategic architecture but rely on partners for execution; others specialise in channel execution without strong strategic capability. Clarify which combination your organisation needs before engaging.
– Data and analytics depth: the commercial value of an omnichannel programme is determined by the quality of the data and analytics that power it. Evaluate whether the agency has genuine data science capability or relies on the reporting tools built into the CRM or marketing automation platform.
– Regulatory and compliance expertise: omnichannel engagement in life sciences operates within strict promotional compliance frameworks. Ensure the agency has experience managing MLR review processes, compliant content workflows, and the regulatory constraints that govern HCP and patient communications in your key markets.
– Technology platform experience: different agencies have different levels of expertise with specific CRM and engagement platforms. If you have an existing technology infrastructure, ensure the agency has demonstrated experience working within it.
– Therapeutic area and channel context: the optimal omnichannel architecture for an oncology product differs significantly from that for a primary care medicine. Ensure the agency has experience with your specific therapeutic area and the channel preferences of your target HCP audience.
– Measurement orientation: the strongest life science omnichannel agencies measure programme performance in commercial outcomes, including prescribing rate improvement and HCP engagement quality metrics, not solely in reach or impression volume.
15 Questions to Ask a Life Sciences Omnichannel Agency Before You Hire
1. What is your experience designing and executing omnichannel strategy solutions for life sciences in our therapeutic area?
2. How do you approach HCP segmentation and channel mix design, and what data sources do you use to inform your recommendations?
3. What is your methodology for designing next-best-action recommendation models for field and digital channel coordination?
4. How do you integrate field CRM and digital engagement data to create a unified HCP engagement profile?
5. What is your approach to modular content development, and how do you ensure that content can be personalised for different HCP segments and channels within a compliant workflow?
6. How do you manage promotional compliance and MLR review processes across omnichannel content and campaign execution?
7. What technology platforms do you have the deepest experience with, and how would you approach our specific technology infrastructure?
8. How do you measure the commercial impact of an omnichannel programme, and what KPIs do you use to connect engagement metrics to prescribing outcomes?
9. What does your engagement model look like, and how senior is the team that will work directly with us throughout the programme?
10. How do you approach the coordination of field force and digital engagement, and what workflows have you designed to ensure that field and digital interactions reinforce each other?
11. What is your experience with patient omnichannel engagement, and how do you design programmes that connect patient support and digital touchpoints with HCP engagement strategy?
12. How do you approach omnichannel programme design for markets with different regulatory environments and channel preferences?
13. What is the typical time from engagement to launch for an omnichannel programme of our scope, and what are the most common causes of delay?
14. How do you build internal omnichannel capability within the client organisation alongside delivering the programme?
15. What makes your approach to multichannel marketing in life sciences distinct from that of other agencies, and what specific commercial outcomes have you delivered for clients with similar challenges?
1. What is your experience designing and executing omnichannel strategy solutions for life sciences in our therapeutic area?
Omnichannel engagement in oncology requires different HCP targeting, content strategies, and channel architectures from those appropriate for primary care or rare disease. Ask for specific examples of omnichannel programmes designed for your therapeutic area, including the channel mix, content strategy, and commercial outcomes achieved.
2. How do you approach HCP segmentation and channel mix design, and what data sources do you use to inform your recommendations?
Effective omnichannel strategy in life sciences begins with understanding which channels different HCP segments prefer, how their channel preferences have shifted post-pandemic, and how those preferences interact with prescribing behaviour. Ask specifically what data sources the agency uses to inform channel mix decisions, and how it validates that its channel recommendations reflect actual HCP engagement patterns rather than industry assumptions.
3. What is your methodology for designing next-best-action recommendation models for field and digital channel coordination?
Next-best-action is the operational core of effective omnichannel HCP engagement, determining which channel, which message, and which timing is most likely to generate a positive commercial response for each individual HCP. Ask how the agency builds these models, what data they require, how quickly they update as engagement behaviour changes, and how field teams receive and act on the recommendations they generate.
4. How do you integrate field CRM and digital engagement data to create a unified HCP engagement profile?
The fundamental technical challenge of life sciences omnichannel is creating a single, continuously updated HCP profile that reflects every interaction across field, digital, events, and medical affairs channels. Ask specifically how the agency approaches this data integration challenge, what technology infrastructure it requires, and how it manages the latency between an engagement event and its reflection in the unified profile.
5. What is your approach to modular content development, and how do you ensure that content can be personalised for different HCP segments and channels within a compliant workflow?
Modular content is the content architecture that makes personalisation at scale commercially feasible in life sciences, enabling a single body of approved content to be recombined for different audiences, channels, and regulatory markets without requiring individual MLR approval for each variation. Ask specifically how the agency designs modular content systems, how it manages the MLR approval workflow, and how many approved content modules a programme of your scope typically requires.
6. How do you manage promotional compliance and MLR review processes across omnichannel content and campaign execution?
Compliance is not a post-design consideration in life sciences omnichannel but a structural constraint that shapes how content is created, how channels are configured, and how engagement data is collected and used. Ask how the agency embeds compliance requirements into its programme design from the outset, and what its track record is for running compliant omnichannel programmes without material post-approval revision.
7. What technology platforms do you have the deepest experience with, and how would you approach our specific technology infrastructure?
Life science omnichannel marketing requires integration across multiple technology platforms including CRM, digital engagement tools, approved email systems, event management platforms, and analytics infrastructure. Ask specifically which platforms the agency has deployed most extensively, how it approaches programmes where the client has existing technology that must be integrated, and where it has seen technology infrastructure create commercial constraints on programme design.
8. How do you measure the commercial impact of an omnichannel programme, and what KPIs do you use to connect engagement metrics to prescribing outcomes?
An omnichannel programme measured only in engagement volume, such as email opens or digital content views, is not being measured in the way that matters commercially. Ask specifically how the agency connects HCP engagement data to prescribing behaviour change, what analytical methodology it uses to attribute commercial outcomes to specific channel investments, and how it has demonstrated commercial return on comparable programmes.
9. What does your engagement model look like, and how senior is the team that will work directly with us throughout the programme?
The commercial quality of a life science omnichannel marketing programme depends heavily on the seniority and sector experience of the people designing it. Ask specifically who will lead the strategy and programme design work, what their direct experience in pharmaceutical omnichannel is, and how the agency structures its engagement model for programmes of your scope and complexity.
10. How do you approach the coordination of field force and digital engagement, and what workflows have you designed to ensure that field and digital interactions reinforce each other?
The most commercially effective life sciences omnichannel programmes are those where digital engagement reinforces field interactions in a timed, personalised way, and where field representatives have visibility of an HCP’s digital engagement before each visit. Ask specifically how the agency designs the data flows and workflow triggers that make this coordination operationally possible, and what the typical latency is between a digital engagement event and its reflection in the field team’s CRM.
11. What is your experience with patient omnichannel engagement, and how do you design programmes that connect patient support and digital touchpoints with HCP engagement strategy?
In chronic and specialty disease markets, patient engagement and HCP engagement are commercially interconnected: the quality of patient support infrastructure influences HCP confidence in prescribing, and the information HCPs share with patients shapes their engagement with support programmes. Ask how the agency designs programmes that coordinate HCP and patient engagement in a way that reinforces both.
12. How do you approach omnichannel programme design for markets with different regulatory environments and channel preferences?
Multichannel marketing in life sciences operates differently across markets: digital channel preferences vary significantly between the US, Europe, and Asia Pacific, and regulatory constraints on promotional communications differ materially across jurisdictions. Ask specifically how the agency adapts its programme architecture for different markets, and how it manages the compliance and localisation requirements of global omnichannel deployments.
13. What is the typical time from engagement to launch for an omnichannel programme of our scope, and what are the most common causes of delay?
Life sciences omnichannel programmes frequently take longer to launch than initially planned, and the most common causes of delay, including data integration challenges, MLR review timelines, and field adoption issues, are predictable and manageable if addressed in the programme design. Ask specifically what the agency’s typical launch timeline is, where delays most commonly occur, and how it proactively manages those risks.
14. How do you build internal omnichannel capability within the client organisation alongside delivering the programme?
An omnichannel programme that requires ongoing external agency dependency to operate is a commercial limitation rather than a capability. Ask specifically how the agency transfers omnichannel strategy and execution knowledge to internal commercial teams, what training and toolkits it provides, and how it has built internal capability in comparable pharmaceutical organisations.
15. What makes your approach to multichannel marketing in life sciences distinct from that of other agencies, and what specific commercial outcomes have you delivered for clients with similar challenges?
The answer to this question reveals whether the agency’s differentiation is genuine or positional, and whether its commercial results are measurable or anecdotal. Ask for specific commercial outcomes, including prescribing rate changes, HCP engagement quality improvements, and field adoption metrics, from programmes it has run for clients with challenges comparable to yours.
Looking for the Right Life Sciences Omnichannel Agency to Work With?
Life science omnichannel marketing requires a partner that brings together the strategic expertise, data capability, content infrastructure, and regulatory awareness to build engagement programmes that generate commercial outcomes rather than engagement volume. As multichannel marketing in life sciences becomes the standard rather than the differentiator, the competitive advantage shifts to the quality of execution, the sophistication of the data and analytics layer, and the commercial orientation of the agency designing the programme.
Why Choose G&CO.?
G&CO. works with life sciences and biotech companies to design omnichannel strategy solutions for life sciences that connect every channel in a commercially coherent, data-driven engagement architecture. Through the Acumen platform, G&CO. provides the brand and consumer intelligence that informs which channels, messages, and engagement approaches generate the strongest commercial return with each audience, ensuring that omnichannel investment is directed with precision rather than deployed broadly.
Submit an inquiry to G&CO. on our contact page or click on the blue "Click to Contact Us" button on the bottom right corner of your screen for your convenience. We look forward to hearing from you.
